cardiology careers collections past issues search home
     

J Am Coll Cardiol, 2006; 47:2172-2179, doi:10.1016/j.jacc.2006.01.063 (Published online 12 May 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiménez-Quevedo, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiménez-Quevedo, P.

Vascular Effects of Sirolimus-Eluting Versus Bare-Metal Stents in Diabetic Patients

Three-Dimensional Ultrasound Results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial

Pilar Jiménez-Quevedo, MD*, Manel Sabaté, MD, PhD*,*, Dominick J. Angiolillo, MD{dagger}, Marco A. Costa, MD, PhD{dagger}, Fernando Alfonso, MD, PhD*, Joan Antoni Gómez-Hospital, MD, PhD{ddagger}, Rosana Hernández-Antolín, MD, PhD*, Camino Bañuelos, MD*, Javier Goicolea, MD, PhD§, Francisco Fernández-Avilés, MD, PhD||, Theodore Bass, MD, Javier Escaned, MD, PhD*, Raul Moreno, MD*, Cristina Fernández, MD, PhD*, Carlos Macaya, MD, PhD* for the DIABETES Investigators

* San Carlos University Hospital, Madrid, Spain
{dagger} University of Florida Cardiovascular Imaging Core Laboratories, Jacksonville, Florida
{ddagger} "Prínceps d'Espanya" University Hospital, Barcelona, Spain
§ "Do Meixoeiro" University Hospital, Vigo, Spain
|| Clínico University Hospital, Valladolid, Spain


Figure 1
View larger version (19K):

[in a new window]
 
Figure 1 (Top panels) Histograms of neointima hyperplasia (NIH) volume in the sirolimus-eluting stent (SES) group (left) and the bare-metal stent (BMS) group (right). A non-Gaussian distribution is demonstrated in both groups (Kolmogorov-Smirnov test: p < 0.0001 for SES group; p = 0.02 for BMS group). The median test evidenced significant differences between groups. (Bottom panels) Histograms of percent volume obstruction in the SES group (left) and the BMS group (right). A non-Gaussian distribution is demonstrated in both groups (Kolmogorov-Smirnov test: p < 0.0001 for SES group; = 0.03 for BMS group). The median test evidenced significant differences between groups.

 

Figure 2
View larger version (18K):

[in a new window]
 
Figure 2 Patterns of vascular changes at proximal (top panels) and distal edges (bottom panels). In the bare-metal stent group (left), negative remodeling (reduction in external elastic membrane [EEM] volume), led to a reduction in luminal volume despite small reductions in plaque volume. In the sirolimus-eluting stent group (right), vessel enlargement (increase in EEM volume) encompassed an increase in plaque volume, resulting in a net gain in lumen volume. *p = 0.09; {dagger}p = 0.04; {ddagger}p = 0.05; §p = 0.001; ¶p = 0.03 (post-procedure versus 9-month follow-up p values).

 

Figure 3
View larger version (112K):

[in a new window]
 
Figure 3 (Top) Intravascular imaging of a stent completely apposed immediately after the implantation. (Bottom) Same artery imaging at nine-month follow-up: Late acquired incomplete stent apposition is evidenced.

 




 
  cardiology careers collections past issues search home